Stem cells from a healthy eye, when transplanted into a damaged eye, safely restored corneal surfaces in 14 patients who were ...

Symbiosis’ completion of the FDA regulatory review is expected to increase the company’s commercial-scale sterile manufacturing capabilities.

Researchers say study findings have important implications for our understanding of the pathogenesis of obesity and potential therapeutic applications.

A gene therapy to correct a mutation that causes maple syrup urine disease prevented newborn death and normalized growth in a calf as well as in mice.

Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...

Enhanc3D Genomics has announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery. The new 3D multi-omics offerings were designed to ...

Representatives from four leading companies highlight emerging basic and clinical research that drives renewed optimism.

Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to support ...

These discoveries could have important medical implications, including diagnostic tests for causes of infertility linked to genome folding.

Tecan has announced their latest product Veya™, a liquid handling platform designed to bring efficiency, precision, and compliance to laboratories of all sizes. The platform was showcased at the SLAS ...

Researchers are conducting studies to help understand how diabetes drugs affect glucose excretion, the gut microbiome, and their metabolic products.

After an illustrious career, including 12 years as director of the NIH and leading the HGP consortium, Francis Collins announces his sudden resignation.